For hypertensive patients undergoing spinal surgery, remimazolam is associated with a significantly lower risk of intraoperative hypotension and fewer adverse events compared to propofol, suggesting it may be a safer anesthetic option for this population.
Jing Cui (Thu,) studied this question.